Sponge-Inspired Dibromohemibastadin Prevents and Disrupts Bacterial Biofilms without Toxicity by Le Norcy, T et al.
marine drugs 
Article
Sponge-Inspired Dibromohemibastadin Prevents and
Disrupts Bacterial Biofilms without Toxicity
Tiffany Le Norcy 1, Hendrik Niemann 2, Peter Proksch 2, Karen Tait 3, Isabelle Linossier 1,
Karine Réhel 1, Claire Hellio 4,* and Fabienne Faÿ 1
1 Laboratoire de Biotechnologie et Chimie Marines, Institut Universitaire Européen de la Mer,
Université de Bretagne-Sud, 56100 Lorient, France; tiffany.le-norcy@univ-ubs.fr (T.L.N.);
isabelle.linossier@univ-ubs.fr (I.L.); karine.rehel@univ-ubs.fr (K.R.); fabienne.fay@univ-ubs.fr (F.F.)
2 Institute of Pharmaceutical Biology and Biotechnology, Heinrich-Heine-University Düsseldorf,
40225 Düsseldorf, Germany; hendrik-niemann@web.de (H.N.); peter.proksch@hhu.de (P.P.)
3 Plymouth Marine Laboratory, Plymouth PL1 3DH, UK; KTAIT@pml.ac.uk
4 Biodimar, LEMAR UMR 6539, Institut Européen de la Mer, Université de Bretagne Occidentale,
29200 Brest, France
* Correspondence: Claire.hellio@univ-brest.fr
Received: 2 June 2017; Accepted: 6 July 2017; Published: 12 July 2017
Abstract: Since the banning of several families of compounds in antifouling (AF) coatings, the search
for environmentally friendly AF compounds has intensified. Natural sources of AF compounds have
been identified in marine organisms and can be used to create analogues in laboratory. In a previous
study, we identified that dibromohemibastadin-1 (DBHB) is a promising AF molecule, leading to
the inhibition of the activity of phenoloxidase, an enzyme involved in the attachment of mussels to
surfaces. This paper describes the activity of the DBHB on biofilm formation and its detachment
and on bacterial adhesion and communication: quorum sensing. DBHB has an anti-biofilm activity
without affecting adhesion of marine and terrestrial bacteria at a dose of 10 µM. Moreover, DBHB
activity on quorum sensing (QS) is demonstrated at doses of 8 and 16 µM. The activity of DBHB on
QS is compared to kojic acid, a quorum sensing inhibitor already described. This compound is a
promising environmentally friendly molecule potentially useful for the inhibition of microfouling.
Keywords: biofouling; biofilm; bastadin derivative; microfouling; quorum sensing; sponge
1. Introduction
All surfaces immersed in aquatic environments are rapidly colonized by organisms (microfoulers
and macrofoulers); this natural phenomenon is defined as biofouling [1].
It is occurring in three main sequential stages: immediately after immersion, surfaces are covered
by dissolved organic molecules which then stimulate subsequent adhesion of microorganisms such as
bacteria, fungi and microalgae; these organisms constitute the microfouling. It acts as attractant for the
adhesion of macrofoulers such as macroalgae (zygote and/or spores) and invertebrate larvae [2–4].
Within biofilms, bacteria are usually present in higher densities than in other microorganisms.
These bacterial communities are constituted by sessile bacteria, which are adhered to each other
and/or to the surface, with the adhesion being facilitated by the production of exopolysaccharides
(EPS) [5]. The formation of microbial biofilm is a complex process which involves communication
such as quorum sensing (QS). QS is a microbial signaling system which allows for the regulation of
population behaviors such as the production of virulence factors [6] or the formation of biofilm [7].
The QS system involves small molecules named autoinducers (AI). These molecules, linked to the
protein receptor, induce the expression of several genes involved in population behaviors such as
biofilm formation, motility or pigment production. One of the family of QS signal molecules are
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acyl-homoserine lactone (AHL) type molecules. This bacterial communication was first described in a
marine bacteria Vibrio fisheri [8]. Later, similar signaling systems were discovered in other bacterial
species. Two systems are described: in Gram negative bacteria, AHL-like communication molecules
are present, whereas in Gram positive bacteria, other molecules (autoinducer-2: pheromones) are
identified [9]. It was described that QS plays an important role in numerous processes governing
biofilm formation and organization. Waters et al., demonstrated that when Vibrio cholera was in low
cell density, the phosphorylation of LuxO inhibited an mRNA which induced the expression of a
protein inhibiting the C-di-GMP. The C-di-GMP, an intracellular messenger, has already been shown
to be involved in bacterial biofilm formation [7]. In the same way, P. aeruginosa mutated on the lasI
gene induced a biofilm 20% finer than the wild type [10]. The discovery of a molecule which could
interfere with the QS and especially with the biofilm formation would be a promising candidate for
new antifouling (AF) compound [11] in replacement of current AF compounds used in paint, such as
heavy metals or biocides.
Some compounds have attracted wide-spread attention for their ability to interact with QS. For
example, molecules of the furanone family are able to interfere with bacterial communication [12,13].
These compounds possess a chemical structure similar to the structure of AHL [14]. Other molecules,
some enzymes (lactonase or acylase) could be used to inhibit QS [15]. For example, an enzyme named
Aiia is able to inhibit the QS by the degradation of the lactone ring of AHL, which is involved in the
recognition of the receptor [16].
The environment is a source of inspiration for many innovations. In nature, numerous marine
organisms which are fixed and/or moving slowly are able to inhibit biofouling [17,18]. Numerous
bioactive substances have been isolated from marine organisms such as algae and sponges [19,20]. Such
compounds contribute, in most cases, to the chemical defense against predation, or to the inhibition of
adhesion and growth of pathogens and epibionts. Sponges are pre-eminent producers of bioactive
secondary metabolites with antibacterial, antifungal or anti-inflammatory activities [21–23]. From
natural molecules, it is also possible to synthesize analogues, which possess equivalent or even stronger
activities, due to the addition of specific chemical groups [24–26].
Within this study, we decided to focus on the potential of bastadins as AF inhibitors. Bastadins
have been previously isolated from a marine sponge Ianthella basta. Thirty natural bastadins were
characterized and screened for their AF potencies: it was highlighted that some of these compounds
were able to inhibit barnacle adhesion and adhesives synthesis by mussels [27,28].
Bastadins are composed of a brominated tyrosine and a brominated tyramine unit linked by a
peptide bond in order to form a hemibastadin unit (Figure 1A). The tyrosine moiety furthermore
bears an oxime function. Two hemibastadins linked by covalent bonds give rise to a bastadin. Within
this study, we focused on the characterization of the activity of a hemibastadin analogue named
dibromohemibastadin-1 (DBHB) (Figure 1B). DBHB consists of a hemibastadin unit composed by
brominated tyrosine and a likewise brominated tyramine unit; its synthesis was previously described
by Bayer et al. in 2011 [27]. DBHB is selected and evaluated in our study because this compound has
already been described as an inhibitor of macroorganisms (barnacles and mussels) adhesion [28,29]
without toxicity. However, its activity on microorganisms has never been described. Microorganisms
are important in biocorrosion, and these organisms can develop resistance against biocides, so it is
important to identify new molecules and strategies to limit biofouling. Ortlepp et al. in 2007 published
data about DBHB activity toward cyprid larvae of Barnacle improvisus and nauplii of Artemia salina:
DBHB induced an inhibition of the larval settlement at 10 µM without mortality and did not cause
mortality of the brine shrimp nauplii when used at 10 µM [29]. The importance of the oxime function
and bromine atoms for AF activity was also highlighted. Bayer et al. in 2011, showed that DBHB
inhibits phenoloxydase (enzyme involved in adhesive production by Mytilus sp.) activity with an IC50
of 0.84 µM [27].
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Figure 1. Chemical structure of a natural bastadin (A) and the hemibastadin analogue: 
Dibromohemibastadin-1 DBHB (B). 
The aim of our work is to further characterize the activity of DBHB, with a focus on marine and 
terrestrial bacterial adhesion and biofilm formation. These experiments have been realized in 
dynamic conditions, in a flowcell system, established by Tolker-Nielsen [30]. The molecule has also 
been tested on bacterial communication to determine its mode of action. 
2. Results 
2.1. Anti-Bacterial Activity 
To determine the antibacterial property of DBHB, the activity of the molecule was evaluated on 
the growth of four bacteria, three marine bacteria (Paracoccus sp. 4M6, Pseudoalteromonas sp. 5M6 and 
Vibrio sp. D66) isolated in the Gulf of Morbihan (south Brittany) [31] and a terrestrial bacterium 
Pseudomonas aeruginosa PAO1 used as reference. DCOIT was used as positive control, it is the active 
compound of the seanine® [32]. 
Results do not show any statistical differences (ANOVA, p > 0.05) unlike to the addition of the 
DCOIT, which induced an inhibition of the bacterial percentage by a factor of 4 (Figure 2). The 
inhibition of bacterial growth by the DCOIT is statistically different to the control (ANOVA, p < 0.01). 
 
Figure 2. Screening of dibromohemibastadin-1 (DBHB) at six concentrations on two bacteria: Paracoccus sp. 
4M6 and Pseudomonas aeruginosa PAO1 (* p < 0.01); the bar represents the standard deviation. 
The anti-bacterial test showed that DBHB does not affect the bacterial growth at doses between 
0.02 and 80 µM. DBHB is not toxic for the bacteria studied. 
To evaluate the activity of the compound DBHB on bacterial adhesion and biofilm, the 
concentration tested varied from 2 to 16 µM. This range of concentration was selected for the next 
experiments because these concentrations were high enough for activity evaluation. 
Figure 1. Chemical structure of a natural bastadin (A) and the hemibastadin analogue:
Dibromohemibastadin-1 DBHB (B).
The aim of our work is to further characte ize the activity of DBHB, with a focus on mari e and
terrestrial bacterial adhesion and biofilm form tion. These experiments have been realiz d in dynamic
conditio s, in a flowcell syste , established by Tolker-Nielsen [30]. The molecule has also been tested
on bacterial communication to determine its mode of action.
2. Results
2.1. Anti-Bacterial Activity
To determine the antibacterial property of DBHB, the activity of the molecule was evaluated on
the growth of four bacteria, three marine bacteria (Paracoccus sp. 4M6, Pseudoalteromonas sp. 5M6
and Vibrio sp. D66) isolated in the Gulf of Morbihan (south Brittany) [31] and a terrestrial bacterium
Pseudomonas aeruginosa PAO1 used as reference. DCOIT was used as positive control, it is the active
compound of t e seanin ® [32].
Results d not show any statistical differences (ANOVA, p > 0.05) u like to the addition of the
DCOIT, which induced an inhibition of the bacterial percentage by a factor of 4 (Figure 2). The inhibition
of bacterial growth by the DCOIT is statistically different to the control (ANOVA, p < 0.01).
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Figure 2. Screening of dibromohemibastadin-1 (DBHB) at six concentrations on two bacteria: Paracoccus sp.
4M6 and Pseudomonas aeruginosa PAO1 (* p < 0.01); the bar represents the standard deviation.
The anti-bacterial test h wed that DBHB does not af ect the b cterial growth at doses between
0.02 and 80 µM. DBHB is not t xic for he bacteria studied.
To evaluate the activity of the compound DBHB on bacterial adhesion and biofilm, the concentration
tested varied from 2 to 16 µM. This range of concentration was selected for the next experiments
because these concentrations were high enough for activity evaluation.
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2.2. Impact of DBHB on AHL Production
Amongst the four strains studied (PAO1, 4M6, 4J6 and 5M6), three were shown to be able to
produce AHLs. However, no AHL was identified in the supernatant of Pseudoalteromonas sp. 5M6.
The AHL identification is presented in Table 1.
Table 1. Identification of acyl-homoserine lactones (AHLs) produced by P. aeruginosa PAO1,
Paracoccus sp. 4M6, Bacillus sp. 4J6 and Pseudoalteromonas sp. 5M6.
Bacterial Strains Gram AHL Produced
Pseudomonas aeruginosa PAO1 Negative C4-HSL, C6-HSL and 3-oxo-C12-HSL
Paracoccus sp. 4M6 Negative C4-HSL, C6-HSL, C8-HSL and 3-oxo-C10-HSL
Bacillus sp. 4J6 Positive Autoinducer-2
Pseudoalteromonas sp. 5M6 Negative No. AHL
The two bacteria gram negative P. aeruginosa PAO1 and Paracoccus sp. 4M6 produce three or
four different AHLs. For the other gram negative bacterium, Pseudoaltermonas sp. 5M6, no AHL
was identified. It is probable that this bacterium produces another kind of communication molecule.
For the last bacterium, Bacillus sp. 4J6, in gram positive bacterium, other molecules of communication
have been identified in the literature (Autoinducer-2, AI-2) [33,34].
The addition of DBHB does not modify the AHL production, chromatograms of P. aeruginosa
PAO1, Paracoccus sp. 4M6; and Pseudoalteromonas sp. 5M6, with or without DBHB, were similar.
2.3. Anti-Adhesion Activity
DBHB activity was evaluated on the adhesion of the marine bacterium Paracoccus sp. 4M6 and
of the terrestrial bacterium Pseudomonas aeruginosa PAO1. The molecule activity was determined in
the flowcell system [30]. The addition of DBHB in both conditions (within the bacterial growth media
or by conditioning the adhesion surface) did not induce any inhibition or activation of the adhesion
of P. aeruginosa PAO1 or Paracoccus sp. 4M6 in comparison to the control. Figure 3 summarizes the
observations obtained by Confocal laser scanning microscopy (CLSM) on the adhesion of P. aeruginosa
PAO1 and Paracoccus sp. 4M6 on the glass slide.
Mar. Drugs 2017, 15, 222 4 of 17 
 
2.2. Im act of DBHB on AHL Production 
Amongst the four strains studied (PAO1, 4M6, 4J6 and 5M6), three were shown to be able to 
produ e AHLs. However, no AHL was identified in the supernatant of Pseudoalteromonas sp. 5M6. 
The AHL identification is presented in Table 1. 
Table 1. Identification of acyl-homoserine lactones (AHLs) produced by P. aeruginosa PAO1, 
Paracoccus p. 4M6, Bacillus sp. 4J6 and Pseudoalteromonas sp. 5M6. 
Bacterial Strains Gram AHL Produced 
Pseudomonas aeruginosa PAO1 Negative C4-HSL, C6-HSL and 3-oxo-C12-HSL 
Paracoccus sp. 4M6 N gative C4-HSL, C6-HSL, C8-HSL and 3-oxo-C10-HSL 
Bacillus sp. 4J6 Positive Autoinducer-2 
Pseudoalteromonas sp. 5M6 Negative No. AHL 
The two bacteria gram negative P. aeruginosa PAO1 and Paracoccus sp. 4M6 produce three or four 
diff rent AHLs. For the other gram negative bacterium, Pseudoaltermonas sp. 5M6, no AHL was 
identified. It is probable that this bacterium produces another kind of communication molecule. For 
the last bacterium, Bacillus sp. 4J6, in gram positive bacterium, other molecules of communication 
have been identified in the literature (Autoinducer-2, AI-2) [33,34]. 
The addition of DBHB does not modify the AHL production, chromatograms of P. aeruginosa 
PAO1, Paracoccus sp. 4M6; and Pseudoalteromonas sp. 5M6, with or without DBHB, were similar. 
2.3. Anti-Adhesion Activity 
DBHB activity was evaluated on the adhesion of the marine bacterium Paracoccus sp. 4M6 and 
of the terrestrial bacterium Pseudomonas aeruginosa PAO1. The molecule activity was determined in 
the flowcell system [30]. The addition of DBHB in both conditions (within the bacterial growth media 
or by conditioning the dhesion surface) did not induce any inhibition or activation of the adhesion 
of P. aeruginosa PAO1 or Paracoccus sp. 4M6 in comparison to the control. Figure 3 summarizes the 
observations obtained by Confocal laser scanning microscopy (CLSM) on the adhesion of P. 
aeruginosa PAO1 and Paracoccus sp. 4M6 on the glass slide. 
 
Figure 3. Confocal laser scanning microscopy observations of the bacterial adhesion with syto9® after 
2 h with addition of DBHB at 16 µM in two conditions (A: PAO1 control, D: 4M6 control, B,E: addition of 
DBHB to the bacterial suspension for PAO1 and 4M6, C,F: conditioning of the adhesion surface for PAO1 
and 4M6); the overlap percentage (%) is added on observations, the ± represents the standard deviation. 
Figure 3. Confocal laser scanning microscopy observations of the bacterial adhesion with syto9®
after 2 h with addition of DBHB at 16 µM in two conditions (A: PAO1 control, D: 4M6 control, B,E:
addition of DBHB to the bacterial suspension for PAO1 and 4M6, C,F: conditioning of the adhesion
surface for PAO1 and 4M6); the overlap percentage (%) is added on observations, the ± represents the
standard deviation.
Mar. Drugs 2017, 15, 222 5 of 18
It was also observed that the strain P. aeruginosa PAO1 adhered far more than the bacterium
Paracoccus sp. 4M6, there was a factor of 4 between the overlap percentages of P. aeruginosa PAO1 and
Paracoccus sp. 4M6. This difference of overlap percentage was statistically different (p < 0.01) and could
be explained by the different ability of the bacteria to adhere.
2.4. Anti-Biofilm Activity
2.4.1. Biofilm Formation
The impact of DBHB was observed on the biofilm formation. The activity of the molecule was
tested on Gram negative bacteria, which produce AHL (Paracoccus sp. 4M6 and P. aeruginosa PAO1),
on a gram negative bacteria and which did not produce AHL (Pseudoalteromonas sp. 5M6), as well as
on a Gram positive bacterium (Bacillus sp. 4J6). AHL production was determined after an extraction
and a LC–MS–MS dosage (Data are not shown) [35].
For the strain P. aeruginosa PAO1, observations obtained in CLSM are shown in Figure 4.
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Figure 4. Observation of P. aeruginosa PAO1 biofilms (syto9®) with addition of DBHB at four
concentrations (2, 8, 16 and 32 µM) in the medium growth flow, biovolumes (µm3/µm2) and biofilms
percentages (%) are presented; the ± represents the standard deviation.
For P. aeruginosa PAO1, the inhibition of the biofilm was statistically different from the control
only at 16 and 32 µM. At 2 and 8 µM the biofilm was inhibited by only a factor of 1.3. The standard
deviations at 2 and 8 µM DBHB was higher than those observed for 16 and 32 µM DBHB, this explains
why the biofilm inhibition was not statistically different after analysis with the ANOVA and Tukey
tests. During these experiments, the strain P. aeruginosa PAO1 at times formed filaments in biofilm and
these filaments could modify the biofilm structure and the biovolume associated. The modification
of the biofilm structure in P. aeruginosa PAO1 could be linked to environmental factors (temperature,
pH . . . ). This is why the activity of biofilm inhibition is not the same for the different concentrations
evaluated; in flowcell system, it was not possible to control the filament formation. The activity of the
compound DBHB was evaluated towards a second strain, a Gram negative bacteria producing AHL:
the marine bacterium Paracoccus sp. 4M6 (Figure 5).
For the strain Paracoccus sp. 4M6, the addition of DBHB to the growth medium induced
an inhibition of the biofilm which was significantly different from the control at the four tested
concentrations. The biovolumes of Paracoccus sp. 4M6 biofilm were 2.1, 2.6, 2.5 and 3.2 times lower
than the control for the addition of DBHB at 2, 8, 16 and 32 µM respectively. The similarity of these two
bacteria is their ability to produce AHL and their membrane composition, as both are Gram negative
bacteria. DBHB is an anti-biofilm compound, but its activity is not permanent. If the molecule is
diluted or removed, the biofilm is formed and the biovolume is not significantly different from the
control (p > 0.05). To inhibit biofilm formation, DBHB has to be in contact with the bacteria.
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Figure 5. Observation of Paracoccus sp. 4M6 biofilms (syto9®) with addition of DBHB at four
concentrations (2, 8, 16 and 32 µM) in the medium growth flow, biovolumes (µm3/µm2) and biofilms
percentages (%) are presented; the ± represents the standard deviation.
In order to determine the spectrum of activity of DBHB, a marine bacterium which did not
produce AHL (Pseudoalteromonas sp. 5M6) and a marine Gram positive bacterium (Bacillus sp. 4J6)
were also tested and compared (Table 2).
Table 2. Biovolumes of Bacillus sp. 4J6 and Pseudoalteromonas sp. 5M6 biofilms calculated for the control
condition and after addition of DBHB at 16 and 32 µM in the growth medium flow; the ± represents
the standard deviation.
Bacterial strains Control 6 µM DBHB 32 µM DBHB
4J6 biovolumes (µm3/µm2) 18.9 ± 1.8 21.5 ± 1.9 22.5 ± 1.7
5M6 biovolumes (µm3/µm2) 22.0 ± 1.5 21.9 ± 1.3 22.1 ± 1.8
ANOVA - -
TUKEY - -
-: no statistical difference, p > 0.05.
The addition of DBHB in the growth medium flow at 16 and 32 µM did not significantly disturb
the biofilm formation of Bacillus sp. 4J6 and Pseudoalteromonas sp. 5M6. Biovolumes of Bacillus sp.
4J6 and Pseudoalteromonas sp. 5M6 biofilms wer not ifferent from the control con itio (about
20 µm3/µm2 for both bacteria w th or without addition of DBHB). In this stu y, the molecule DBHB
seemed to have a specific action on Gram negative bacteria which produce AHL, but more strains
should be tested to confirm this result. As it was described that Gram negative bacteria are dominant
in the marine environment, it is interesting to have an antibiofilm property on dominant bacteria in
seawater [36].
2.4.2. Biofilm Degradation
The second way to evaluate the ability of DBHB to interfere with the biofilm’s behavior was to
observe the impact of the compound on a biofilm already formed. DBHB was tested on two strains:
Paracoccus sp. 4M6 and P. aeruginosa PAO1 (Table 3).
After a contact time of wo ours between the bacterial biofilm and DBHB, the biofilm was
observed. Biofilms that had already been formed were degraded the addition of the DBHB in the
channel flowcell. There was a factor of inhibition of 3 between the biovolume of the control biofilm
(with biovolumes values of 12.9 ± 1.9 µm3/µm2 for 4M6 and 14.6 ± 1.3 µm3/µm2 for PAO1) and the
biovolume after the contact with the DBHB (4.6 ± 1.1 µm3/µm2 for 4M6 and of 4.5 ± 0.4 µm3/µm2
for PAO1). These results were proved to be significantly different by a ANOVA (p < 0.01) test in
comparison with the control.
To validate the activity of DBHB on biofilm formation without an interaction on the bacterial
viability, a staining with syto9® and sytoxRed® was performed.
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Table 3. Biovolumes of PAO1 and 4M6 biofilms tagged with syto9® and sytoxRed® to observe the
impact of DBHB at 32 µM on the bacterial viability, the ± represents the standard deviation.
Biovolumes (µm3/µm2)
Paracoccus sp. 4M6 Pseudomonas aeruginosa PAO1
Control 32 µM DBHB Control 32 µM DBHB
Living cells (Syto9®) 12.7 ± 1.3 4.9 ± 0.1 14.7 ± 1.0 4.3 ± 1.0
Dead cells (SytoxRed®) 0.2 ± 0.1 0.3 ± 0.1 0.2 ± 0.02 0.2 ± 0.03
Mortality percentage 0.98 0.94 0.98 0.95
ANOVA - -
TUKEY - -
-: no statistical difference, p > 0.05.
The CLSM observations and the biovolume measurements showed that the addition of DBHB
did not induce cells mortality within the biofilm. The percentage of altered cells tagged in red
concomitantly with biovolume value (Table 1) indicated that DBHB did not have toxicity against those
bacteria. Indeed, the biovolume of dead cells between the control and the biofilm after addition of
DBHB were not significantly different (ANOVA and Tukey tests).
2.5. Anti-Quorum Sensing Activity
Continuing the demonstration of DBHB activity on biofilm formation, another test using a
biosensor, E. coli pSB401, was performed in order to determine further biological properties of the
compound on bacterial communication. In presence of AHL, the plasmid pSB401 containing QS genes
in E. coli induces a luminescence which was possible to quantify. If DBHB has an impact on QS genes
(luxCDABE), the luminescence production would be inhibited by the biosensor E. coli pSB401.
The luminescence production controlled by the recognition between AHL and the receptor is
presented Figure 6. An inhibition of the luminescence was observed when the biosensor was in contact
with DBHB. The inhibition appeared to be proportional to the concentration of DBHB and the molecule
did not alter E. coli growth. The control displayed a classical curve of recognition between AHL
and the receptor inducing the luminescence. The addition of DBHB at 8 and 16 µM inhibited the
luminescence and the maximum values were respectively 1.7 and 2 times lower than those of the
control. This inhibition is statistically different from the control (ANOVA and Tukey, p < 0.01). When
using kojic acid, which is already known as a quorum sensing inhibitor, the inhibition was 20 times
lower, as compared to the control.
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To validate the anti-quorum sensing property of DBHB and the absence of interaction of
the compound with the luminescence production, another biosensor, V. harveyi JAF548, was used.
For this second biosensor, the bioluminescence production is not dependent of AHL presence. If the
luminescence produced by V. harveyi JAF548 is inhibited, the molecule would not interact on QS
genes but on the luminescence biosynthesis. Figure 7 presents the ratio between the bioluminescence
emission and the optical density of V. harveyi JAF548 for the control condition and after the addition of
DBHB at doses of 8 and 16 µM.
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The biosensor V. harveyi JAF548 validates the absence of activity of DBHB on the bioluminescence
production, confirming the anti-quorum sensing property of DBHB. At the maximum bioluminescence
(4 h of growth), the production was not significantly different between the control condition and the
addition of DBHB (ANOVA, p > 0.05).
3. Discussion
3.1. Anti-Bacterial Activity
DBHB is not toxic toward the bacteria studied. The absence toxicity is an i portant factor in
order to allow the utilization of a new co pound in an antifouling coating to be used in the natural
environ ent. Nowadays, in order to authorize a new biocide, the olecule ust have nu erous
require ents in order to obtain a arketing authorization, such as an absence of toxicity against
referent organisms, and not be bioaccumulable. In Europe, a regulation on biocidal products (RBP) is
established for the validation and use of biocides [37].
show that DBHB does not impact the AHL producti n by P. aeruginos PAO1 and Paracoccus
sp. 4M6. Some quoru sensing inhibitor can degrade or pe turb the AHL synthesis. For example,
some bacteria produce enzymes such as lactonase or acylase, which can degrade AHL [15]. Without
AHL, the bacterial communication is inh bited. By targeting the QS, it is possible to inhibit bacterial
adhesion or biofilm maturation, which are important steps in microfouling [38].
Mar. Drugs 2017, 15, 222 9 of 18
3.3. Anti-Adhesion Activity
Experiments realized to assess the potential interaction of the DBHB on the bacterial adhesion,
showed that no significant difference from the control was obtained for the bacteria Paracoccus sp. 4M6
and for Pseudomonas aeruginosa PAO1. DBHB cannot inhibit the bacterial adhesion.
Other experiments not presented is this study showed that DBHB did not modify bacterial motility
of P. aeruginosa PAO1: swimming, swarming and twitching. For this motility processes, two kinds
of organelles, pili and flagellum, were used. Studies published that these organelles are involved
in bacterial adhesion and biofilm structuration [39,40]. These results confirmed that DBHB did not
impact cellular mechanism allowing the bacterial adhesion.
3.4. Anti-Biofilm Activity
For both strains Paracoccus sp. 4M6 and P. aeruginosa PAO1, DBHB led to an interesting activity on
biofilm formation and biofilm desintegration. The marine strain Paracoccus sp. 4M6 was more sensitive
than the terrestrial bacterium P. aeruginosa PAO1. From tested conditions in this study, DBHB has a
specific activity towards Gram negative bacteria which produce AHL.
Gram negative bacteria possesses a complex cell wall, the DBHB could target a specific
compound of the Gram negative cell wall which is not present in Gram positive bacteria, such as a
lipopolysaccharide; it could cross the bacteria wall by porin protein [41]. In Gram negative bacteria,
the outer membrane protects bacteria against antibiotics, detergents or other molecules [42]. It is
an interesting result for antifouling application because, in the marine environment, Gram negative
bacteria are dominant [36].
DBHB seems also able to target bacterial strains which produce bacterial signal molecule such as
AHL; it is possible that this molecule can interfere in quorum sensing.
DBHB was derived from natural bastadins isolated from the marine sponge Ianthella basta.
It was not surprising to find antibiofilm compounds in marine sponge; these organisms need to
produce chemical defenses for their survival [43], against predation or for space and competition for
resources [44,45]. Two classes of marine sponge compounds were previously identified as antibiofilm
molecules without interaction on the bacterial viability, which include terpenoids [46] and the pyrrole
imidazoles [47]. Some of these compounds are presented in Table 4.
Table 4. Antibiofilm compounds derived from marine sponges without killing bacteria or disrupting
their growth.
Classes Compounds Activity References
Terpenoids Ageloxime-D antibiofilm, antimacrofouling [17,46]
Manoalide antibiotic, anti-inflammatory, anti-quorum sensing [48]
Pyrrole-imidazole
alkaloids
Oroidin antibiofilm, antifouling [49–51]
Sceptrin antifouling, anti-quorum sensing [52]
Bromoageliferin anti-adhesion, antibiofilm [47,53]
Natural compounds which have this type of activity are a source of numerous analogues with
biological activities. In this study, the bastadin analogue DBHB was found to be a promising antifouling
compound, because this molecule can inhibit biofilm formation without interacting with bacterial
growth. DBHB has a simple structure and can be easily synthesized.
DBHB is not the first compound exhibiting bromine atoms that show antibiofilm properties. Other
studies have confirmed the antibiofilm property of brominated compounds, for example, in 2008
Huigens et al. showed that the increase of brominated groups in a given molecular structure induced a
stronger antibiofilm activity [54]. In another study of Andjouh et al. in 2016, the authors demonstrated
the importance of bromine groups for the antifouling performance [55].
An example to consider is the compound oroidin, isolated from the sponge Agelas oroides.
The molecule has been described as an inhibitor of bacterial adhesion [56]. Forte et al. in 2009,
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showed that oroidin can inhibit P. aeruginosa biofilm with IC50 of 190 µM. Structurally, oroidin and
DBHB are similar, with two aromatic cycles and bromines. By comparing, IC50 of these two molecules
on the inhibition of P. aeruginosa biofilms, DBHB appeared to be twenty times more active than
oroidin [57].
Another explanation of DBHB effect could be an interaction with an intracellular pathway, such
as with the C-di-GMP. This intracellular messenger is involved in biofilm formation and dispersion.
In P. aeruginosa, the level of C-di-GMP induced the extracellular matrix synthesis by the activation of
pel and psl genes [58].
3.5. Anti-Quorum Sensing Activity
The study with the biosensor E. coli pSB401 demonstrated an anti-QS property of DBHB. The
addition of DBHB induces a reduction of the luminescence production; however, this inhibition is not
similar to the activity of kojic acid. Kojic acid is described as an inhibitor of QS, which is explained by
chemical similarities between AHL and kojic acid. The latter compound was identified as an AHL
analogue. Kojic acid can bind to QS receptors such as RhlR, LasR or LuxR and block the communication
system [59]. The difference on the inhibition of the bacterial communication by DBHB or acid kojic
could be explained by the mode of action of the molecule. It is known that kojic acid possesses a
direct activity on QS, as the molecule is an antagonist of AHL, while DBHB could interact on a step of
regulation in the QS, which does not induce a total inhibition of the luminescence produced by the
biosensor. With these results, we can hypothesize that DBHB does not interact in the same way as kojic
acid does on the AHL receptor.
The second biosensor, V. harveyi JAF548 confirmed the activity of DBHB on QS and not on the
bioluminescence production. Indeed, the strain V. harveyi JAF548 produces bioluminescence which is
not under the control of QS. The absence of inhibition of bioluminescence validated the interaction of
DBHB with QS [60].
Five steps of QS inhibitions were described, (i) compounds can interact on the biosynthesis of
AHL; (ii) compounds can degrade QS signal molecules; (iii) compounds can inhibit AHL efflux protein;
(iv) compounds can interact on transcriptional activator or (v) compounds can be considered as QS
analogues [61]. It is possible that DBHB can interact on one of four of the last steps described.
DBHB is not the first derivative of compounds from sponges which presents an activity on
QS. Another group of marine-sponge-derived compounds was demonstrated to be quorum sensing
inhibitors: the manoalide family (Table 2). Extracts from the marine sponge Luffariella variabilis were
shown to act as quorum sensing inhibitors [62], but the site of action has never been described before
for these molecules. It is difficult to define precisely the action of a molecule on the QS because a lot of
interactions are possible in the cell. Until now, some natural compounds were described as quorum
sensing inhibitors; most compounds identified were able to inhibit the QS receptor such as manoalide
or sceptrin type compounds [59]. To find new anti-quorum sensing compounds is an interesting way
to disturb microbial communication linked in microfouling [63]. Some studies explained that they
are links between QS and biofilm formation, but other studies described that too many pathways
are involved to show a direct effect of QS on biofilm [64]. With genomic tools, it will be possible to
determine the way of action of the molecule.
DBHB has already been described as an antifouling compound; the molecule can inhibit
macrofoulers colonization. Its activity on an enzyme, the phenoloxydase, which occurs in the mussel
adhesion, was described (IC50 = 0.8 µM) [28]. The compound was also identified as an inhibitor of
the barnacle adhesion (10 µM) [29]. In this study, DBHB is able to inhibit bacterial biofilm maturation
(PAO1: IC50 = 10.2 µM and 4M6: IC50 < 2 µM) without toxicity, a possible explanation is that DBHB
can interact on bacterial communication. Comparatively to macrofoulers, Gram-negative bacteria were
less sensitive than mussels at DBHB, the IC50 to inhibit biofilm maturation is 2 at 10 times higher than
the enzymatic activity. All these data make DBHB a promising antifouling agent.
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4. Materials and Methods
All chemical products were purchased from Sigma Aldrich except the syto9® which was
purchased in Fisher scientific. DBHB had been synthesized at the Institute of pharmaceutical biology
and biotechnology (Heinrich-Heine-University Düsseldorf, Germany) [27].
4.1. Bacterial Strains and Growth Conditions
Marine bacteria selected for this study were Paracoccus sp. 4M6 (Gram negative, 1 OD =
4.8 × 107 CFU/mL), Pseudoalteromonas sp. 5M6 (Gram negative, 1 OD = 3.5 × 107 CFU/mL) and
Bacillus sp. 4J6 (Gram positive, 1 OD = 4.2 × 107 CFU/mL). These marine bacteria were isolated from
glass slides immersed for 6 h in the Morbihan gulf, France [65]. Paracoccus sp. 4M6 was selected
for its ability to produce bacterial signal molecules: acyl homoserine lactone (AHL). In contrast,
Pseudoalteromonas sp. 5M6 was chosen as a model species as it does not produce any AHL. Finally,
Bacillus sp. 4J6 was selected as a representative of Gram positive bacteria. The three strains were
maintained and cultivated at 20 ◦C using Zobell media (ASW 30 g/L, Tryptone 4 g/L, Yeast extract
1 g/L). Bacterial cultures were incubated at 106 UFC/mL for 48 h under agitation.
The biosensor Vibrio harveyi JAF548 was used to validate the absence of activity of DBHB on
bioluminescence production [66]. The strain was grown in MB medium (37.5 g/L) supplemented with
kanamycin at 30 µg/mL.
Two terrestrial bacterial strains were also selected. Pseudomonas aeruginosa PAO1 to evaluate
antibiofilm activity (1 OD = 2.7.108 CFU/mL), because it is a bacterium well known for biofilm
formation and communication processes. The second terrestrial bacterium is the biosensor
Escherichia coli pSB401 used to describe the anti-quorum sensing property. Terrestrial strains were
maintained and cultivated at 37 ◦C in Luria Bertani, LB (NaCl 10 g/L, Tryptone 10 g/L, Yeast extract
5 g/L) for 24 h under agitation.
All experiments (anti-adhesion, anti-biofilm activities) were realized using Paracoccus sp. 4M6 and
P. aeruginosa PAO1, however the remaining marine bacteria (Pseudoalteromonas sp. 5M6, Bacillus sp. 4J6,
V. harveyi JAF548 and E. coli pSB401) were used to complete the activity of the DBHB on different bacteria.
4.2. Impact of DBHB on AHL Production
AHL was extracted and identified in four strains: Pseudomonas aeruginosa PAO1, Paracoccus sp.
4M6, Bacillus sp. 4J6 and Pseudoalteromonas sp. 5M6.
AHL extraction and identification processes were performed using the methodology described
by Morin et al. [35]. The effect of DBHB was evaluated at three concentrations (16, 32 and
80 µM). In cultures with and without DBHB, AHL were extracted with dichloromethane in bacterial
supernatants. The organic phase was dried and AHL were suspended with acetonitrile. Extracts were
injected in LC–MS (microTOF-QII, Bruker, Billerica, MA, USA) and AHL were identified by analysis of
the retention time and spectrum obtained [67]. All extractions were realized in triplicate.
4.3. Anti-Bacterial Activity
DBHB anti-bacterial activity was evaluated at six concentrations: 0.02, 0.08, 0.2, 2, 16 and
80 µM. Bioassays were run in twelve replicates. The screening was performed on Paracoccus sp.
4M6, Pseudoalteromonas sp. 5M6 and Pseudomonas aeruginosa PAO1. Bacterial cultures of 24 h for PAO1
and 48 h for 4M6 and 5M6 were diluted at 106 CFU/mL and added the microplate containing DBHB to
a final volume of 200 µL in a 96-welle microplate in polypropylene. DBHB was added in the first step
to allow the evaporation of the solvent (methanol). A positive control consisted of bacteria without
DBHB and for the negative control DCOIT (4,5-Dichloro-2-octyl-4-isothiazolin-3-one) was added at
0.1 µg/mL. Microplates were incubated at 20 ◦C for 48 h for 4M6 and 5M6, and at 37 ◦C for 24 h
for PAO1.
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After the incubation the optical density at 600 nm was measured to determine the impact of DBHB
on bacterial growth. By a comparison to the control, a bacterial inhibition percentage was determined.
4.4. Anti-Adhesion Activities
In order to evaluate the anti-adhesion properties of DBHB, experiments were realized in a
flowcell [30]. The flowcell was prepared by sticking a microscope coverslip 24 × 50 mm2 (VWR) slide
which is the support of adhesion. The flowcell is presented on the Figure 8.Mar. Drugs 2017, 15, 222 12 of 17 
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The system was sterilized by a flow of bleach (1.5%) for 24 h at 430 µL/min. Then a flow of minimum
medium, a saline solution (NaCl 9 g/L) for the terrestrial bacterium: Pseudomonas aeruginosa PAO1 or an
artificial sea water (ASW 30 g/L) for marine bacteria (Paracoccus sp. 4M6, Pseudoalteromonas sp. 5M6 and
Bacillus sp. 4J6) was activated to clean and prepare the system for the bacterial injection at 150 µL/min.
The bacterial solution was prepared from a bacterial culture which was inoculated overnight.
A dilution of the bacterial suspension was realized to inject bacteria at 106 CFU/mL in minimum
medium. Using a 1 mL syringe, 250 µL of the inoculum was injected in every channel. The flowcell
was turned over to facilitate the bacterial adhesion on the microscope coverslip. Bacteria were allowed
to attach to the glass surface during 2 h in static condition. For PAO1, the flowcell was incubated at
37 ◦C, and for 4M6 the flowcell was incubated at 20 ◦C.
To quantify the anti-adhesion activity, two assays were performed. Firstly, DBHB was added in
the flowcell at 16 µM in the bacterial inoculum immediately prior to injection (Condition 1 in Table 5).
The concentration of DBHB was determined from results obtained by a screening against bacteria
and microalgae (results are not presented). We decided to evaluate the activity of DBHB in lower
concentration at 16 µM due to a limitation of DBHB quantity available at the time. Also, to evaluate
DBHB activity on bacterial adhesion, the molecule was used to prepare the support of adhesion. DBHB
was added at 16 µM in the minimal medium flow. It was used to clean the surface during two h at
150 µL/min (Condition 2 in Table 5). A condition without addition of DBHB was used as a control.
After two hours of adhesion, the flow at 150 µL/min was activated during 30 min with the aim
to remove free bacteria. Adhered bacteria were observed with Syto9® nucleic acid stain at 5 µM
(λexcitation = 488 nm, λemission = 498–540 nm). The bacterial adhesion was observed with confocal laser
scanning microscopy (Zeiss, LSM 710, Oberkochen, Germany) by using a 40× oil immersion objective.
For every studied parameter, a triplicate was realized (27 observations per condition). The overlap
percentage was determined with a JAVA program established in the lab. This program determines a
percentage between black and green pixels.
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Table 5. Anti-adhesion and anti-biofilm conditions evaluated with DBHB.




1 Addition in the bacterial suspension
2 Conditioning of the adhesion surface
Anti-biofilm
2, 8, 16 and 32 µM P. aeruginosa PAO1Paracoccus sp. 4M6 Biofilm formation: addition in the growth medium
flow (dynamic: 150 µL/min)
16 and 32 µM Pseudoalteromonas sp.5M6 Bacillus sp. 4J6
16 µM P. aeruginosa PAO1Paracoccus sp. 4M6
Biofilm degradation: injection of media containing
the compound on a biofilm formed (static: 2 h)
4.5. Anti-Biofilm Acitivities
In order to evaluate the anti-biofilm property of DBHB on three marine bacteria (Paracoccus sp.
4M6, Pseudoalteromonas sp. 5M6 and Bacillus sp. 4J6) and on one terrestrial bacterium P. aeruginosa
PAO1, a test in a flowcell was performed. To observe the biofilm formation, a flow of medium growth at
120 µL/min (LB for P. aeruginosa PAO1 or Zobell for Paracoccus sp. 4M6, Pseudoalteromonas sp. 5M6 and
Bacillus sp. 4J6) was activated during 24 h for P. aeruginosa PAO1 or 48 h for marine bacteria to allow
the biofilm formation under dynamic condition. Then, bacteria were stained with the same procedure
as the adhesion part with syto9® and the biofilm was observed by confocal laser scanning microscopy.
The biovolume and the thickness of biofilms were determined with the COMSTAT program [68].
To highlight a potential anti-biofilm property of DBHB, two tests were realized. Firstly, DBHB
activity on the biofilm formation was assessed. In this case, DBHB was added to the growth medium
flow at 2, 8, 16 and 32 µM. Secondly, DBHB activity on the biofilm degradation was examined. For this
second test, DBHB in solution at 16 µM in growth medium was injected in a channel with a formed
biofilm. DBHB was left in contact with the biofilm for 2 h and the flow was activated to clean the
channel before CLSM observations. The inhibition factor was calculated by a ratio between the
percentage of biofilm between the control (bacteria without DBHB, 100%) and the percentage of
biofilm obtained by the addition of the compound. For every concentration, a triplicate is realized
(27 observations per condition).
The bacterial viability was measured using a double tagging by syto9® nucleic acid stain and
sytox red® nucleic acid stain (λexcitation = 633 nm, λemission = 645–695 nm). The viability percentage was
determined from biofilm biovolume.
4.6. Anti-Quorum Sensing Activities
In order to measure and characterize DBHB potential effect on QS, a biosensor was used. This
biosensor constituted of a strain of Escherichia coli containing the plasmid pSB401. This plasmid harbors
a luxCDABE gene which induces a luminescence when the promotor is activated in presence of AHL,
the C6-HSL at 500 ng/mL. The selection of E. coli containing the plasmid pSB401 was controlled by a
resistant gene at the tetracycline (10 µg/mL).
The test was carried out using a polypropylene 96-well black microplate. C6-HSL was used at
500 ng/mL to activate the biosensor; acetonitrile was used as carrier solvent for the AHL and was
eliminated by evaporation under a laminar flow hood for 30 min. The 96-well was inoculated with
E. coli pSB401 at 106 UFC/mL in LB media with tetracycline at 10 µg/mL. DBHB was added at 8
and 16 µM to obtain a final volume of 200 µL per well. The 96-well microplate was incubated at
30 ◦C under agitation for 8 h. Every hour the Optical Density at 600 nm and the luminescence were
measured (TECAN, infinite M200pro). A known inhibitor of quorum sensing, kojic acid, was also
tested at 35 µM [59].
In order to validate the absence of bioluminescence production inhibition, another biosensor
was used: Vibrio harveyi JAF548 was mutated on luxOD47E, the protein LuxO was maintained in
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a phosphorylated stage which allows continuous bioluminescence production. In this biosensor,
the bioluminescence production is not controlled by quorum sensing and it is activated in continuous.
To evaluate the activity of DBHB, the bioluminescence emission reported to the optical density
was measured every hour for twelve hours. A total of 100 µL of AB medium [69] containing the
kanamycin at 30 µg/mL, Vibrio harveyi JAF548 at 106 UFC/mL and DBHB evaluated at 2 and 8 µM
were dropped. The experiment was performed in polypropylene 96-well black microplate.
All experiments were run in six replicates.
4.7. Statistical Analysis of Data
The means are reported± standard deviation (SD). The effect of the compound DBHB on bacterial
adhesion, biofilm formation, biofilm degradation, bacterial viability and bacterial communication
were tested using the one-factor analysis variance (ANOVA) and the Tukey test (HSD). The level of
significance was set to p < 0.01. Values are means ± standard deviation.
5. Conclusions
It was already shown that bacterial signal molecules such as AHL are involved in relationships
between bacteria and other organisms, inlcuding microalgae [70] and macroorganisms (Ulva spores,
Balanus cyprids) [71]. Targeting the bacterial communication system is an interesting strategy to inhibit,
first, the microfouling by disruption of bacteria and diatom biofilms and, second, the macrofouling by
the reduction of macrofoulers attachment. Dibromohemibastadin is a promising antifouling compound
and we can now describe a first approach of this compound for the inhibition of microfouling.
In order to understand the way of action for this compound, a study on biofilm formation and
quorum sensing was realized. DBHB was able to inhibit biofilm formation without acting on the
adhesion step. The biosensor used, a modified E. coli strain, highlighted an interaction of DBHB
with bacterial communication. The use of natural or analogue compounds, which have an impact on
quorum sensing and biofilm formation, could be an interesting strategy to inhibit microfouling and
macrofouling. In addition, the absence of toxicity of DBHB on bacteria is an important factor to consider
that would allow DBHB to be applied as an AF agent. To evaluate the activity of DBHB on biofouling,
it will be interesting to integrate the compound in a coating and immerse it un-natural environment.
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